AstraZeneca Newsroom

Biogen (BIIB.US) and UCB's lupus new drug, daclizumab, late-stage trial successful, reversing early failures.

On Tuesday, BaiHealth and its Belgian partner UCB announced that the experimental lupus treatment drug Darzalex achieved the main goal in late-stage trials.

Zhitong Finance15minutes ago

Express News | Astrazeneca Pharmaceuticals India Limited's stock price expanded by 10%.

Breakings12:11

Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug

BenzingaSep 23 23:43

Black Diamond Reports Encouraging Phase 2 Data for BDTX-1535

Seeking AlphaSep 23 22:10

AstraZeneca Antibody Drug Candidate Fails to Meet Overall Survival Goal in Breast Cancer

Seeking AlphaSep 23 21:31

AstraZeneca's Cancer Drug Could Secure FDA Approval Despite Final Trial Let-Down

WSJSep 23 21:14

Shares of AAP, SHOP, GEHC, and Others Join a 'Mind the Gap' List

Seeking AlphaSep 23 20:52

Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Monday Ahead of Key Inflation Data

MT NewswiresSep 23 20:27

AstraZeneca's Inflammatory Disease Drug Recommended for EU Approval

MT NewswiresSep 23 19:21

AstraZeneca and Daiichi Sankyo Report Data From Phase III Breast Cancer Trial

Yahoo FinanceSep 23 18:52

AstraZeneca's Market Position and Drug Pipeline Sustain Buy Rating Despite TB01 Trial Results

TipRanksSep 23 18:36 · Ratings

Express News | Astrazeneca breast cancer treatment trial did not meet expectations

BreakingsSep 23 17:00

Astrazeneca (AZN.US) breast cancer treatment trial did not meet expectations, stock price pre-market fell by 1.4%.

The experimental anti-cancer drug Datoxumab, jointly developed by AstraZeneca and Daiichi Sankyo Co., Ltd., failed to prolong the survival of patients in the breast cancer treatment trial.

Zhitong FinanceSep 23 16:45

FDA Approves AstraZeneca FluMist 'Flu Vaccine for Self-administration

Yahoo FinanceSep 23 16:32

AstraZeneca's Trial Result Is Another Disappointment for Its Cancer Drug -- Market Talk

WSJSep 23 16:21

European Markets in Green as Traders Assess Latest Economic Data

Seeking AlphaSep 23 15:55

AstraZeneca Hits 8-week Low

Trading EconomicsSep 23 15:00

AstraZeneca's Fasenra Set to Transform EGPA Treatment

TipRanksSep 23 14:42

Daiichi Sankyo and AstraZeneca's Datopotamab Deruxtecan Falls Short on Survival in Breast Cancer Trial

BenzingaSep 23 14:42

CHMP Recommends AstraZeneca's Fasenra For Approval In Eosinophilic Granulomatosis With Polyangiitis

RTTNewsSep 23 14:41